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Background: Oryeongsan (OR) is an herbal medication used in east-Asian traditional medicine to treat dysuresia,
such as urinary frequency, hematuria, and dysuria due to renal disease and chronic nephritis. Recent studies
showed that protective effect against acute gastric mucosal injury and an inhibitory effect on the renin-angiotensin-
aldosterone pathway of OR. However, its effect on inflammation still remains unknown. In this study, to provide insight
into the biological effects of OR, we investigated their effects on lipopolysaccharide (LPS)-mediated inflammation in
the RAW 264.7 macrophage cells.
Methods: We investigated the pharmacological and biological effects of OR on the production of pro-inflammatory
cytokines, inflammatory mediators, and related products through Enzyme-linked immunosorbent assay (ELISA), reverse
transcription-polymerase chain reaction (RT-PCR) and Western blot analysis. Also, we examined the activation and
suppression of nuclear factor (NF)-kappaB and mitogen-activated protein kinases (MAPKs) pathways in LPS-stimulated
macrophages via Western blot analysis in order to explore inhibitory mechanism of OR.
Results: OR had anti-inflammatory effects by inhibiting the production of nitric oxide (NO), tumor necrosis factor
(TNF)-alpha, interleukin (IL)-6, and IL-1beta. In addition, it strongly suppressed cyclooxygenase (COX)-2 and inducible
nitric oxide synthase (iNOS), NO synthesizing enzymes. It also induced heme oxygenase (HO)-1 expression and
inhibited NF-kappaB signaling pathway activation and phosphorylation of MAPKs.
Conclusions: We further demonstrate the anti-inflammatory effects and inhibitory mechanism of OR in LPS-stimulated
macrophages for the first time. OR contains strong anti-inflammatory activity and affects various mechanism pathways
including NF-kappaB, MAPKs and HO-1. Our results suggest that OR has potential value to be developed as an
inflammatory therapeutic agent from a natural substance.
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OR is a traditional ancient herbal medication in East
Asia. It is a prescription described in the Sanghanron, an
ancient Chinese medical book. OR is composed of five
medicinal herbs including Alisma Rhizome, Atractylodes
Rhizome White, Chuling, Poria and Cinnamon Bark. OR is
currently prescribed for the treatment of edema, dizziness,
vomiting and symptoms associated with renal disease. A
previous study demonstrated that OR protects against
ethanol-induced acute gastric mucosal injury [1]. Another
study revealed that OR has an inhibitory effect on the
renin-angiotensin-aldosterone system in rats [2]. Addition-
ally, recent studies have shown that amelioration of strep-
tozotocin diabetes-induced renal damage by OR [3]. It has
also been reported that OR exert protective effect on
adriamycin-induced nephrotic syndrome in rats [4]. How-
ever, the effect of OR on inflammation remains unknown.
Inflammation is a normal physiological immune re-
sponse to protect body from infection or tissue injury
and results in activation of various immune cells such as
macrophages, neutrophils, and lymphocytes. In normal
state, inflammatory mediators, such as NO and inflam-
matory cytokines, generated from macrophage cells take
an essential role in host survival and tissue repair [5].
However, these inflammatory mediators are overexpressed
by certain stimuli and could cause autoimmune and in-
flammatory diseases [6-8].
Macrophages play an important role in the regulation of
inflammation and immune responses [6,9]. Specific stim-
uli such as LPS which is endotoxin from gram-negative
bacteria, give rise to activation of macrophages. Activated
macrophages secrete inflammatory mediators such as NO
and prostaglandin (PG)E2 and produce inflammatory cyto-
kines such as TNF-α and IL-6 [5,10]. These inflammatory
mediators and cytokines are essential for host survival
after infection, and are necessary for the recovery of tissue
damage [5]. NO and PGE2 are synthesized by iNOS and
COX-2, respectively, and iNOS expression is closely re-
lated to the induction of HO-1.
HO-1 is a stress-inducible protein that catalyzes the
oxidative degradation of heme. Two other isoforms exist:
HO-2 and HO-3 [11]. HO-1 expression is enhanced not
only by free heme, but also by various pro-inflammatory
stimulants such as NO, LPS, cytokines, heavy metals,
and other oxidants [12,13]. Biliverdin is rapidly trans-
formed into bilirubin, which decreases NO production
and iNOS expression in murine macrophages stimulated
with LPS [14,15]. Carbon monoxide, another product of
heme degradation by HO, inhibits NO secretion and re-
duces inflammation. Thus, enhanced HO-1 production
may result in the reduction of iNOS expression and de-
crease the amount of free radicals [16].
Among the cytokines, TNF-α, IL-6 and IL-1β are im-
portant factors involved in the progression of manyinflammatory diseases. These cytokines can be regulated
by activation of the transcription factor NF-κB. NF-κB is
composed of homo or heterodimeric combinations of
NF-κB/Rel proteins, including Rel (cRel), RelA (p65),
RelB, NF-κB1 (p50) and NF-κB2 (p52) [17]. The main
inducible form is consisting of the p65 and p50 subunit.
NF-κB plays an important role in the expression of in-
flammatory genes, and is involved in the pathogenesis of
rheumatism and other chronic inflammatory diseases
[18]. In unstimulated state, NF-κB is present in the cyto-
plasm attached to the suppressor protein inhibitor of
NF-κB alpha (IκBα), but specific stimulants such as LPS
give rise to free NF-κB through degradation and phos-
phorylation of IκBα [19]. Activated NF-κB is translocated
from the cytoplasm to the nucleus, then binds to the pro-
moter and induces the expression of various inflammatory
genes including iNOS, COX-2, inflammatory cytokines,
and chemokines [20,21]. Previous studies showed that
nuclear translocation of NF-κB promotes the transcrip-
tion of iNOS, COX-2 and inflammatory cytokines includ-
ing TNF-α and IL-6 [22]. Most anti-inflammatory agents
reduce the expression of inflammatory factors via inhib-
ition of NF-κB activity [23].
The MAPK signaling pathway plays an important role
in relaying inflammatory information from the extracel-
lular space to the cytoplasm and nucleus [24]. There are
at least three known pathways of MAPK, such as extra-
cellular signal-regulated kinase (ERK), p38 and c-Jun
NH2-terminal kinase (JNK) MAPK. Activated ERK can
phosphorylate various transcription factors; p38 and
JNK constitute a part of the stress response pathway ac-
tivated by various stimulants induced by specific factors
[25]. MAPK is activated by phosphorylation, and subse-
quently induces the activation of NF-κB pathway and ex-
pression of iNOS gene. A previous study demonstrated
that specific MAPK inhibitors can reduce iNOS gene ex-
pression [26]. In the present study, we evaluated the in-
hibitory effect of OR on inflammation induced by LPS in
RAW 264.7 macrophages. Furthermore, we investigated
whether OR-induced modulation of NF-κB and MAPK
signaling pathways and their influence on HO-1 induc-




Roswell Park Memorial Institute (RPMI) 1640 medium,
fetal bovine serum (FBS), and antibiotics were purchased
from Lonza (Basel, Switzerland). LPS and bovine serum
albumin (BSA) were obtained from Sigma (St. Louis, MO,
USA). A cell-counting kit (CCK) was purchased from
Dojindo Molecular Technologies, Inc. (Kumamoto, Japan).
Various primary and secondary antibodies for Western blot
analysis were purchased from Cell Signaling Technology,
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detection were obtained from eBioscience (San Diego,
CA, USA). RNA extraction and DNA synthesizing kits
were purchased from iNtRON (Sungnam, Korea) and
Bioneer (Daejeon, Korea), respectively. Oligonucleotide
primers were synthesized by Bioneer (Daejeon, Korea).
The standard compounds cinnamic acid and cinnamalde-
hyde were purchased from Sigma (St. Louis, MO, USA),
and atractylenolid III was purchased from Chem Faces
(Wuhan, China). Marker compound purity, as determined
by high-performance liquid chromatography (HPLC), was
higher than 98%. HPLC grade acetonitrile and trifluoroa-
cetic acid (TFA) were purchased from J. T. Baker Inc.
(Philipsburg, NJ, USA). Distilled water (DW) was filtered
through a 0.45-μm membrane filter from ADVANTEC
(Tokyo, Japan) before analysis.
Preparation of herbal decoction OR
OR is composed of five medicinal herbs listed in Table 1.
All herbs were purchased from Yeongcheon Herbal Market
(Yeongcheon, Korea). All voucher specimens were depos-
ited in an herbal tank, placed in 15,000 mL of DW and then
extracted by heating for 3 h at 115°C and under high pres-
sure (Gyeongseo Extractor Cosmos-600, Inchon, Korea).
After extraction, the solution was filtered using standard
testing sieves (150 μm) (Retsch, Haan, Germany), freeze-
dried and kept in desiccators at 4°C before use. The acqui-
sition was 347 g and the yield was 23.2%. The freeze-dried
extract powder was then dissolved in DW, centrifuged at
14000 rpm for 10 min and supernatant was filtered (pore
size, 0.2 μm) and kept at 4°C prior to use.
Cell culture and drug treatment
RAW 264.7 cells were obtained from the Korea Cell Line
Bank (Seoul, Korea) and grown in complete RPMI 1640
medium. The cells were incubated in a humidified 5% CO2
atmosphere at 37°C. To stimulate the cells, the medium
was exchanged with fresh RPMI 1640 medium, and LPS
(200 ng/mL) was added in the presence or absence of OR
(10, 100, 500, or 1000 μg/mL) for the indicated periods.
Cell viability assay
Cytotoxicity was analyzed using a CCK. OR was added
to the cells and incubated for 24 h at 37°C with 5% CO2.
CCK solutions were added to each well and the cellsTable 1 Herbal components and amount of OR decoction
Herbs Amount of herbs (g)
Alisma Rhizome 500
Atractylodes Rhizome White 300
Chuling 300
Poria 300
Cinnamon Bark 100were incubated for another 1 h. Then the optical density
was read at 450 nm using an ELISA reader (Infinite M200,
Tecan, Männedorf, Switzerland).
Measurement of NO production
NO production was analyzed by measuring nitrite in the
supernatants of macrophages incubated with or without
OR. The cells were pretreated with OR and stimulated
with LPS for 24 h. Griess reagent (1% sulfanilamide, 0.1%
naphthylethylenediamine dihydrochloride, and 2.5% phos-
phoric acid) was added to the cultured supernatant and
incubated at room temperature (RT) for 5 min [27]. The
absorbance was read at 570 nm.
Determination of cytokine production
The secretion of inflammatory cytokines TNF-α, IL-6 and
IL-1β was analyzed using an eBioscience mouse ELISA
antibody set (San Diego, CA, USA). The inhibitory effect
of OR was determined by an ELISA reader at 450 nm
absorbance.
Western blot analysis
Expression of various proteins was evaluated by Western
blot analysis according to standard procedures. The cells
were pretreated with OR and stimulated with LPS for the
indicated periods at 37°C. After incubation, the cells were
harvested and resuspended in radio immunoprecipitation
assay (RIPA) lysis buffer (Millipore, Bedford, MA, USA)
with protease and phosphatase inhibitor cocktail (Roche,
Basel, Switzerland). After cell debris was discarded follow-
ing centrifugation, protein concentration was determined
using Bradford’s reagent and equal amounts of protein were
subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). After transferring the proteins
onto a nitrocellulose membrane (Millipore, Bedford, MA,
USA), the membrane was blocked with 3% BSA in Tris-
buffered saline with 0.1% Tween 20 (TBS-T). Then the
membrane was incubated with each primary antibody at
4°C overnight and subsequently incubated with HRP-
conjugated secondary antibodies. Specific proteins were
detected using SuperSignal West Femto Chemilumines-
cent Substrate (Thermo Scientific, Rockford, IL, USA).
Preparation of cytosolic and nuclear extracts for NF-κB
detection
Cytosolic and nuclear fractions were isolated using NE-PER
Nuclear and Cytoplasmic Extraction Reagents (Thermo
Scientific, Rockford, IL, USA) according to the procedure
described by the manufacturer. The fractions were stored
at −80°C before use.
RNA extraction and RT-PCR
Total RNA was isolated using an easy-BLUE™ RNA ex-
traction kit (iNtRON, Daejeon, Korea) according to the





TNF-α F: 5′-AGCACAGAAAGCATGATCCG-3′ 55°C
R: 5′-GTTTGCTACGACGTGGGCTA-3′
IL-6 F: 5′-CATGTTCTCTGGGAAATCGTGG-3′ 58°C
R: 5′-AACGCACTAGGTTTGCCGAGTA-3′
IL-1β F: 5′-TGCAGAGTTCCCCAACTGGTACATC-3′ 64°C
R: 5′-GTGCTGCCTAATGTCCCCTTGAATC-3′
COX-2 F: 5′-CACTCAGTTTGTTGAGTCATTC-3′ 45°C
R: 5′-GATTAGTACTGTAGGGTTAATG-3′
iNOS F: 5′-AGCCCAACAATACAAATGACCCTA-3′ 56°C
R: 5′-TTCCTGTTGTTTCTATTTCCTTTGT-3′
HO-1 F: 5′-TGAAGGAGGCCACCAAGGAGG-3′ 62°C
R: 5′-AGAGGTCACCCAGGTAGCGGG-3′
β-actin F: 5′-ATGAAGATCCTGACCGAGCGT-3′ 58°C
R: 5′-AACGCAGCTCAGTAACAGTCCG-3′
F, forward; R, reverse.
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was transformed into cDNA using AccuPower® CycleScript
RT PreMix (Bioneer, Daejeon, Korea). Specific primers
amplified by PCR are described in Table 2. The fol-
lowing PCR conditions were applied for TNF-α, IL-6,
IL-1β, COX-2, iNOS, HO-1, and β-actin: 35 cycles of de-
naturation at 94°C for 30 s, annealing at the temperature
indicated in Table 2 for 30 seconds, and extension at 72°C
for 30 seconds [27-31].
Preparation of standard solutions and samples
Standard stock solutions of atractylenolid III, cinnamic
acid and cinnamaldehyde were prepared by dissolving
0.2 mg each standard in 1 mL 60% methanol to yield a
final concentration of 200 μg/mL. To prepare analyticalTable 3 HPLC conditions used for the analysis of OR
Item






Flow rate 1.0 mL/min
Inject volume 20 μL
Column OptimaPak C18 (4.6 × 250 mm, 5 μ
Column temperature 40°C
UV wavelength 220 nm
The English in this document has been checked by at least two professional editors
http://www.textcheck.com/certificate/7WNmoy.samples, 10 mg OR extract in 1 mL DW was extracted
by ultra-sonication and filtered through a 0.2-μm syringe
membrane filter from Whatman Ltd. (Maidstone, UK)
before injection into the HPLC system for analysis. All
standard stock and sample solutions were stored at −4°C
in a refrigerator before analysis.
Chromatographic conditions
The HPLC-DAD system (Hitachi, Tokyo, Japan) consisted
of a pump (L-2130), autosampler (L-2200), column
oven (L-2300) and UV/VIS diode array detector (L-2455).
The output signal of the detector was recorded using
EZChrom Elite software for Hitachi. For sample analysis,
an OptimaPak C18 column (4.6 × 250 mm, 5 μm; RS Tech
Co., Daejeon, Korea) was used, and the column oven
temperature was kept at 35°C. The injection volume was
20 μL, and the flow rate of the mobile phase was 1.0 mL/
min. The wavelength of the UV detector was set at 220 nm.
The mobile phase was water containing 0.1% TFA and
acetonitrile, with gradient elution at a flow rate of 1.0 mL/
min (Table 3).
Statistical analysis
The results are expressed as mean ± standard error (SE)
for all experiments. Statistical significance was deter-
mined by Student’s t-tests after comparing each treated
group to the negative control. Each experiment was re-
peated at least three times to yield comparable results.
Values of P < 0.01 and P < 0.001 were considered statisti-
cally significant.
Results
Effects of OR on cell viability and NO production
We first examined OR cytotoxicity at concentrations of
10–1000 μg/mL in macrophages. As shown in Figure 1A,
OR was not cytotoxic up to 1000 μg/mL, indicating thatCondition






m, RS tech Co., Daejeon, Korea)
, both native speakers of English. For a certificate, please see:
Figure 1 Effect of OR on (A) cell viability and (B) NO production induced by LPS stimulation. RAW 264.7 cells were pretreated with OR for
30 min before 24 h incubation with LPS. (A) The cytotoxicity was determined using CCK. (B) The culture supernatant was analyzed for nitrite
production. As a control, the cells were incubated with vehicle alone. Data represent mean ± SE values of duplicate determinations from
three independent experiments. *p < 0.01 and **p < 0.001 were calculated from comparisons with the LPS-stimulation value.
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ition can relieve inflammation, we examined the inhibi-
tory effect of OR on NO generation in RAW 264.7 cells
upon LPS stimulation. Dexamethasone, a well-known
anti-inflammatory drug, was used as a positive control. As
presented in Figure 1B, OR concentration-dependently
suppressed NO secretion with statistical significance. In
particular, OR (1000 μg/mL) inhibited NO secretion to a
similar extent as observed with the positive control.
Inhibitory effect of OR on LPS-induced TNF-α, IL-6 and
IL-1β production
We examined the inhibitory effect of OR on the expres-
sion of TNF-α, IL-6 and IL-1β cytokines, other inflamma-
tory mediators. Cytokine expression was analyzed using
ELISA and RT-PCR analysis. TNF-α cytokine and mRNA
were inhibited by OR treatment in a concentration-
dependent fashion (Figure 2A and D). Consistent with the
TNF-α result, OR also inhibited IL-6 cytokine productionconcentration-dependently (Figure 2B). However, the in-
hibitory effect of OR on IL-6 mRNA expression was negli-
gible, with the exception of the effect of the 1000 μg/mL
concentration (Figure 2D). By contrast, OR slightly inhib-
ited IL-1β cytokine production and strongly repressed
IL-1β mRNA expression (Figure 2C and D).
Inhibitory effect of OR on LPS-induced COX-2 and iNOS
expression, and OR effect on HO-1 induction
COX-2 and iNOS are the synthesizing enzymes of PGE2
and NO, respectively. Therefore, COX-2 and iNOS ex-
pression were next investigated using Western blot and
RT-PCR. As presented in Figure 3A and B, OR suppressed
both protein and mRNA expression of COX-2 and iNOS.
In particular, expression of COX-2 and iNOS protein was
significantly inhibited in a concentration-dependent man-
ner. We also examined HO-1 induction in OR-treated
macrophages, which is known to contribute to the inflam-
matory response. Western blot and RT-PCR analysis
Figure 2 Effect of OR on the expression of (A–C) cytokines and (D) mRNAs. Cells were pretreated with OR for 30 min before being
incubated with LPS for (A–C) 24 h and (D) 6 h. Cytokine production was measured by ELISA and mRNA level was analyzed by RT-PCR. RNA value
was quantitated using an i-MAXTM Gel Image Analysis System (Core Bio, Seoul, Korea). Data represent the mean ± SE values of duplicate determi-
nations from three independent experiments. *p < 0.01 and **p < 0.001 were calculated by comparison with the LPS-stimulation value.
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First, we measured the expression of HO-1 3, 6, 12, and
24 h after 1000 μg/mL OR treatment. HO-1 protein and
mRNA expression were highest at 6 and 3 h, respectively
(Figure 3C). As shown in Figure 3D, OR induced HO-1
protein and mRNA expression at concentrations of 500
and 1000 μg/mL in a concentration-dependent manner.
OR inhibits NF-κB pathway activation in macrophages
upon LPS stimulation
The NF-κB pathway is closely related to the production
of inflammatory cytokines and iNOS. We examined the
effects of OR on NF-κB activation by analyzing p65
translocation into the nucleus and the phosphorylation of
IκBα in the cytosol. Western blot analysis revealed that
100–1000 μg/mL OR significantly repressed p65 trans-
location into the nucleus (Figure 4A). Also, as presentedin Figure 4B, phosphorylation of IκBα was suppressed
in a concentration-dependent manner. Less IκBα was
consistently found in the presence of the same OR con-
centrations. These results suggest that OR effectively
inhibits LPS-induced NF-κB pathway activation by
blocking the nuclear translocation of NF-κB and IκBα
phosphorylation.
OR suppresses LPS-induced phosphorylation of MAPKs in
RAW 264.7 cells
Because MAPKs activated by phosphorylation play an
important role in NF-κB pathway activation, we exam-
ined the inhibitory effect of OR treatment on activation of
the MAPK pathway. We examined the phosphorylation
levels of MAPKs, including ERK 1/2, p38, and JNK. When
RAW 264.7 cells were stimulated with LPS in the presence of
OR, the level of phosphorylated ERK MAPK was significantly
Figure 3 The effects of OR on (A) COX-2, (B) iNOS, (C, D) HO-1 in macrophages. The cells were treated with (A, B) LPS alone or with LPS
and OR for 24 h and (C, D) OR alone for the indicated periods. Protein levels were determined by Western blot analysis, as described in the
Materials and Methods, and were quantitated using a Davinch-chemi™ Chemiluminescence Imaging System CAS-400SM (Core Bio, Seoul, Korea).
mRNA expression was analyzed by RT-PCR. Data represent mean ± SE values of duplicate determinations from three independent experiments.
*p < 0.01 and **p < 0.001 were calculated from comparisons with the LPS-stimulation value.
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not affect p38 or JNK activity (Figure 5B and C). And, we
determined that the total forms of ERK, p38, and JNK
were not affected by OR treatment.
Selection of suitable wavelengths
To find the optimum absorbance for each analyte, we
obtained UV/VIS spectra at a range of 190–400 nm. The
optimum absorbance for all analytes was determined to
be 220 nm according to the individual absorbances:
atractylenolid III, 227 nm; cinnamic acid, 223 nm; andcinnamaldehyde, 218 nm (Figure 6). The qualitative iden-
tification of three standards in OR was achieved using
HPLC and was based on comparisons of UV wavelengths
with those of the standard compounds.
Analysis of the contents using HPLC
The peaks of the three standards appeared at 26.96 min
for cinnamic acid, 29.64 min for cinnamaldehyde and
35.55 min for atractylenolide III. Figure 7 shows that the
standard compounds and mixture sample were separated
successfully and analyzed simultaneously. Identification
Figure 4 Inhibitory effect of OR on (A) NF-κB translocation into the nucleus and (B) IκBα phosphorylation. The cells were treated with
LPS alone or with LPS and OR for 30 min (IκBα) or for 1 h (NF-κB). Protein expression in the cytosol or nucleus was determined by Western blot
analysis. Data represent mean ± SE values of duplicate determinations from three independent experiments. *p < 0.01 and **p < 0.001 were
calculated from comparisons the with LPS-stimulation value.
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sons of their retention times (tR) and chromatograms with
those of the standard compounds (Figure 7).
Discussion
Previous studies on natural herbs and herbal decoctions
using in vitro and in vivo systems have been conducted
to discover potential anti-inflammatory products. OR is
an important formulation in oriental traditional medicine,and has been commonly used to treat symptoms associ-
ated with renal diseases in East Asia since ancient times.
OR has protective effects against acute gastric mucosal in-
jury and an inhibitory effect on the renin-angiotensin-
aldosterone pathway [1,2]. Among the five herbs that
making up OR, the anti-inflammatory effects of Atracty-
lodes Rhizome White have been studied in RAW 264.7
cells [32]. The anti-inflammatory effects of cinnamon bark
and Alisma rhizome have been studied in both in vitro
Figure 5 Effect of OR on MAPK phosphorylation in macrophages: (A) ERK, (B) p38 and (C) JNK. RAW 264.7 cells were treated with OR for
30 min before being incubated with LPS for 30 min. Cell lysates were analyzed by Western blotting using specific antibodies. Data represent
mean ± SE values of duplicate determinations from three independent experiments. *p < 0.01 and **p < 0.001 were calculated from comparisons
with the LPS-stimulation value.
Figure 6 Chemical structures and HPLC DAD spectra of the main constituents of OR.
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Figure 7 HPLC chromatograms of the (A) standard mixture and (B) OR at 220 nm. 1, Cinnamic acid, 26.96 min; 2, Cinnamaldehyde,
29.64 min; 3, Atractylenolide III, 35.55 min.
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tory effects on NF-κB activation [33,34].
In the present study, we demonstrated the anti-
inflammatory activity of OR in RAW 264.7 murine mac-
rophages stimulated with LPS. First, we determined that
OR treatment did not result in cytotoxicity of RAW
264.7 macrophages; it did not affect cell viability up to a
concentration of 1000 μg/mL. NO overproduction is as-
sociated with various inflammatory diseases [35,36], thus
we investigated the inhibitory effects of OR on NO pro-
duction induced by LPS stimulation. OR strongly sup-
pressed NO secretion and inhibited iNOS expression and
also suppressed COX-2 expression in a concentration-
dependent manner. These results indicate that OR has in-
hibitory effects on the production of pro-inflammatory
mediators.
The induction of HO-1 expression was due to a direct
effect on iNOS expression [16]. Therefore, we investigated
whether the inhibitory effect of OR on iNOS expression
was associated with increased HO-1 production. We found
that OR pretreatment at a concentration of 500 μg/mL or
greater induced HO-1 expression in RAW 264.7 macro-
phages, and also determined that it affected the inhibiting
efficacy of NO and iNOS production. This finding suggests
that inhibitory effect of OR on NO production was influ-
enced by not only blockade on activation of NF-κB and
MAPKs pathways but also induction of HO-1 expression.
OR concentration-dependently suppressed the inflam-
matory cytokines TNF-α, IL-6 and IL-1β. NF-κB is a key
transcriptional regulator associated with the cellular re-
sponse to stimuli such as LPS [37-39]. Furthermore, it
plays an important role in cell viability and the expressionof various inflammatory factors including NO, inflamma-
tory cytokines, and PGE2 [40-42]. To investigate whether
the inhibitory effect of OR on the expression of cyto-
kines and inflammatory factors is associated with NF-κB
pathway activity, we measured the effect of OR on NF-κB
nuclear transcription. We found that OR concentration-
dependently inhibited the nuclear transcription of p65
through the inhibition of IκBα degradation by LPS stimula-
tion. These findings are consistent with previous studies
showing that the NF-κB response drives the expression of
iNOS, TNF-α, and IL-6 genes [43-45]. Because of many
anti-inflammatory drugs repress the production of inflam-
matory mediators through inhibition of NF-κB activity, OR
extract could be developed as anti-inflammatory agents.
Because MAPKs activated by LPS are related to iNOS
expression in macrophages [46], we also examined the
inhibitory effect of OR on the phosphorylation of
MAPKs. OR significantly inhibited phosphorylation of
ERK MAPK, but had a little effect on the phosphoryl-
ation of p38 and JNK MAPK. These results indicate that
the inhibitory effect of OR on the phosphorylation of
MAPKs is directly related to inhibition of NF-κB activation
and reduction of inflammatory factor production in RAW
264.7 cells. In this study, we investigated whether OR have
inhibitory activity on various inflammatory mechanisms
including NF-κB, MAPKs and HO-1. As a results, OR
shows strongly biological effect on various signaling path-
ways. This experiment design in vitro inflammation-
related model was fundamental and comprehensive format
in this field.
As shown in Figure 6, we identified three main compo-
nents (cinnamic acid, cinnamaldehyde and atractylenolide
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has anti-inflammatory activities in vitro and in vivo [33].
Additionally, it was demonstrated that atractylenolide III
inhibits LPS-induced TNF-α and NO production in macro-
phages [47]. These facts suggest that the anti-inflammatory
activity of OR might be related to active components of
OR, including cinnamaldehyde and atractylenolide III.
Conclusions
In conclusion, OR had a strong inhibitory effect on NO
secretion, inflammatory cytokines production and ex-
pression of iNOS and COX-2 in LPS-stimulated RAW
264.7 cells. These effects were due to inhibition of NF-κB
activation through suppression of IκBα degradation and
blockade of MAPK phosphorylation. Also, the influence of
OR on HO-1 expression affected the suppression of in-
flammatory factors. These results suggest that OR could
be developed as a new anti-inflammatory agent derived
from natural products.
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